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ABSTRACT
A 17-year-old male patient with history of intraventricular haemorrhage in 2007 underwent a brain MRI scan in 2013 owing
to headache. Brain MRI scan showed an expansive lesion adjacent to the left lateral ventricle infiltrating the anterior
portion of the corpus callosum. After surgery, pathology confirmed a pilomyxoid astrocytoma (PMA), an aggressive
subtype of astrocytoma that occurs predominantly in the hypothalamic-chiasmatic region. On imaging, PMA presents as
a tumour isointense on T1, hyperintense on T2 that enhanced heterogeneously with contrast. The T2 signal is higher than
pilocytic astrocytoma, which indicates the presence of myxoid matrix. These findings on MRI scan have a direct
correlation with a specific pathological finding——monomorphic proliferation of piloid cells in a mucopolysaccharide-rich
matrix. These characteristics associated with the absence of Rosenthal fibres or eosinophilic granules indicated the
diagnosis of PMA. To our knowledge, this is the first case report of PMA affecting the corpus callosum in an adolescent.
INTRODUCTION
In November 2006, an international Working Group of 25
pathologists and geneticists met to suggest a new resolution
for the brain tumours classification——the 2007 World
Health Organization Classification of Tumours of the Cen-
tral Nervous System. The goal of this new classification
was the same of the older ones——grading the brain neo-
plasms. Based on six pathological criteria, these experts
had the difficult task of classifying the tumours predicting
theirs biological behaviour. The pathological criteria
defined were the number of mitosis, presence of necrosis,
vascular endothelial proliferation, nuclear polymorphism,
cellular density and presence of genetic markers.1
The largest category between the primary neoplasms is the
neuroepithelial tissue tumours, which encompass the
astrocytomas. Anaplastic astrocytoma and glioblastoma
are the most aggressive ones, classified as grades III and IV,
respectively. The diffusely infiltrating astrocytomas are
designated as grade II. One of the most benign-behaviours
astrocytomas are the pilocytic one (grade I). However,
there is a more aggressive subtype of pilocytic astrocytoma
(PA), named pilomyxoid, classified as grade II.1,2
The pilomyxoid astrocytoma (PMA) occurs predominantly
in the hypothalamic-chiasmatic region. To our knowledge,
there is no previous case report that described a PMA
affecting the corpus callosum (CC). Here, we describe the
clinicopathological and radiological features of this patient
with new observations.
CLINICAL SUMMARY
An 11-year-old male, previously healthy, was brought to
the emergency room with occipital headache and vomiting
in 2007. He performed a brain CT scan, which showed a
hyperdense area into the lateral left ventricle. A brain MRI
scan performed in the same period confirmed a haemor-
rhagic lesion without abnormal enhancement adjacent to
the CC. No vascular malformation was revealed by the
conventional angiography. As the cause of the haemor-
rhage was not diagnosed, follow-up studies revealed that
haematoma reduced in size and the clinical status of the
patient improved, conservative management was chosen.
The neurosurgery team followed the patient until 2013,
when owing to new intense headaches episodes, a new
MRI scan was requested. The exam showed an expansive
lesion in the left lateral ventricle infiltrating the anterior
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portion of the corpus callosum. The patient was submitted to a
craniotomy followed by resection of the lesion. The details of the
brain MRI scan and the histopathological findings are described
in the foolowing section.
PATHOLOGICAL AND RADIOLOGICAL FINDINGS
Brain MRI scan
The brain MRI scan showed a solid lesion with cystic compound
intraventricular expansive lesion affecting the anterior portion
of the CC body that was hypointense on T1 and hyperintense on
T2/fluid-attenuated inversion-recovery. It enhanced heteroge-
neously after gadolinium injection, presented a haemorrhagic
component with blooming artefact that was hypointense on T2
gradient echo sequence and infiltrated the anterior horn of the
left lateral ventricle predominantly (Figure 1).
PATHOLOGICAL FINDINGS
The pathological study was performed on paraffin-embedded
sections of the tumour. An immunohistochemical study was
already performed for glial fibrillary acidic protein and Ki-67.
The hematoxylin & eosin stain showed a moderately cellularity
neoplasm in a rich myxoid background. The cells were rounded
and oval without significant atypia, and there was a discrete pre-
dominance around the vascular structures (Figure 2a). The glial
Figure 1. Axial brain MRI scan shows an intraventricular expansive lesion with hypointense signal on T1 (a) and hyperintense signal
on FLAIR (b). Axial gradient echo shows the haemorrhagic component (c). Sagittal contrast-enhanced T1weighted shows the lesion
enhanced heterogeneously by the gadolinium (d). It occupies predominantly the anterior horn of the left lateral ventricle——coronal
contrast-enhanced T1 (e) and infiltrates the anterior portion of the corpus callosum——sagittal T1 (f). FLAIR, fluid-attenuated inver-
sion-recovery.
Figure 2. H&E (200): the image shows a moderate cellularity neoplasm, consisting of rounded and oval cells without significant
atypia, embedded in a myxoid stroma (a). GFAP (200): strong positivity to GFAP, confirming the glial phenotype and showing
cells with elongated processes (b). Ki-67: several cells stained with ki-67, demonstrating moderate proliferative index, beyond that
expected for pilocytic astrocytoma and compatible with the diagnosis ofpilomyxoid astrocytoma (c). GFAP, glial fibrillary acidic
protein; H&E, hematoxylin & eosin.
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fibrillary acidic protein study was strongly positive and showed
elongated processes, which confirmed the glial origin of the
tumour (Figure 2b). Moreover, in the ki-67 analysis, some cells
were stained, showing a moderate proliferative index
(Figure 2c). No Rosenthal fibers or eosinophilic granular bodies
were found.
DISCUSSION
The PMA is a more aggressive subtype of PA, classified as World
Health Organization grade II tumour.1,2 Both PMA and PA
occur during the childhood although the PMA affects younger
children and has a second peak of incidence in young adults.
The neurological symptoms are unspecific, including headache
and intracranial pressure increased. The pathological character-
istic of PMA is the monomorphic proliferation of piloid cells in
a mucopolysaccharide-rich matrix, without Rosenthal fibers or
eosinophilic granules, commonly seen in PA.3,4
Traditionally, the PMA is found as a large mass in the hypothal-
amus/optic chiasm, with an H format. Most of the cases (60%)
are suprasellar, with the geometric center in hypothalamus.
However, owing to its expansive characteristic, the PMA gener-
ally invades the adjacent structures, such as deep gray nuclei,
temporal lobes and closer white matter. The others 40% are
located outside of the diencephalon, usually in the temporal
lobe. Less commonly, it may occur in the midbrain, cerebellum,
fourth ventricle and spinal cord.5 We are unaware of other cases
originating in the corpus callosum.6–11 Typically, the presenta-
tion on the MRI scan is a hypointense imaging on T1 and hyper-
intense on T2/fluid-attenuated inversion-recovery sequences. In
about half of the cases, the gadolinium enhancement is strong
and heterogeneous.3,5
In our case, the PMA diagnosis was established in a 17-year-old
patient, with a history of previous haemorrhagic vascular event.
Table 1. Differential diagnostic between PMA and PA3,5,13–15
PMA PA
Clinical features
Age Mean 18 months
(second peak in young adults)
Mean 58 months
Symptoms Signs of increased intracranial pressure Signs of increased intracranial pressure
and visual loss (pathway lesions)
Prognosis Higher recurrence rate than PA Survival rates at 20 years of 70%
Radiological feature
Haemorrhage Common (25%) Rare (less than 8%)
T1WI Large mass uniformly (60%) hypointense Solid-cystic mass
(solid portion is iso/hypointense)
T2WI Hyperintense (homogeneous in 70%) Hyperintense
Diffusion Typically does not restrict Same diffusivity of grey matter
Enhancement Strong and heterogeneous enhancement Strong and heterogeneous enhancement
Leptomeningeal metastases Common Rare
Location Suprasellar (60%) Cerebellum (60%) > Optic nerve/chiasm
(30%)
Pathological features
WHO grade II I
Proliferative index Moderate Lower to moderate
Myxoid stroma Predominant Poor
Calcification Rare Common
Rosenthal fibers Absent Present
Eosinophilic granular bodies Absent Present
Tumour cells Monomorphic Bipolar
Angiocentric patter Frequent Rare
PA, pilocytic astrocytoma; PMA, pilomyxoid astrocytoma; T1WI, T1weighted image; T2WI, T2weighted image; WHO,World Health
Organization.
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The diagnosis was initially obscured by the extent of intraven-
tricular haemorrhage. It was initially considered a vascular
lesion or arteriovenous malformation as the most likely cause of
the haemorrhage
Almost 25% of the cases of PMA bleed,5 which rarely occur in
the PA.5,13,14 The tumour had a heterogeneous gadolinium
enhancement, a pattern that is usually not found in PA as most
of these tumours present a solid-cystic lesion, with a large cystic
component.14,15 However, a heterogeneous enhancement usu-
ally suggest a glial tumour of a higher grade than
lower grade gliomas.3,5,13–15
The final diagnostic was based on pathological findings. The
main characteristics were the matrix predominantly myxoid and
the proliferative index beyond that expected for PA. The absence
of Rosenthal fibers and eosinophilic granular bodies, common
in PA, ratified our hypothesis.3,16
The differential diagnostic between PA and PMA is not simple
but owing to prognostic issues it should be done.17 Some imag-
ing features such as haemorrhagic component, mainly solid
mass, leptomeningeal dissemination and a higher T2 signal
intensity inside the lesion suggest PMA (Table 1). These findings
should alert the paediatric neuroradiologist to this specific diag-
nosis. Moreover, the neuropathologist should be alert to this
hypothesis, to make the differential diagnosis actively, once the
differences could be subtle.
LEARNING POINTS
1. Despite PMA affecting the corpus callosum is a rare
entity, it should be remembered in the differential
diagnosis of lesions in this location;
2. Haemorrhagic component, mainly solid mass,
leptomeningeal dissemination and a higher T2 signal
intensity inside the lesion suggest PMA.
3. The differential diagnosis is with vascular lesion or
arteriovenous malformation.
CONSENT
Written informed consent for the case to be published (incl.
images, case history and data) was obtained from the
patient(s) for publication of this case report, including
accompanying images.
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